Clinical Trial Update: Vancomycin Reduction Practices (VRP) in the NICU [NA]

View source ↗

Summary

The VRP in the NICU trial is currently recruiting to study vancomycin reduction practices for neonatal sepsis, including late-onset cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Neonatal Sepsis
• Neonatal Sepsis

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Antibiotic Stewardship, Neonatal Sepsis, Late-Onset | NA | Status: RECRUITING